Skip to main content
. Author manuscript; available in PMC: 2013 Aug 6.
Published in final edited form as: Biol Blood Marrow Transplant. 2008 Oct;14(10):1108–1117. doi: 10.1016/j.bbmt.2008.07.006

Figure 2.

Figure 2

Cumulative incidence of cGVHD (A) and autoimmune cytopenias (B, C) in very young infants compared to older children undergoing UCBT. (A) The cumulative incidence of cGVHD in the infant population (solid line) compared to a historic control group of all other metabolic patients treated at Duke (dotted line). (B) The cumulative incidence of autoimmune cytopenias in the study patients (solid line) compared to the older control group of all other metabolic patients treated at Duke (dotted line). (C) The cumulative incidence of cytopenias without other manifestations of cGVHD between the infants (solid line) and older children (dotted line).